Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Mar 30 · below the Ichimoku cloud · RSI 24 (oversold) · MACD below its signal · at its 52-week low
| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $883.5K | 0.00% | 742.40K | −5.8% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a MGX trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Reid Laurence EDirector | Purchase at price 1.17 - 1.18 per share. | 20K | $23.40K |
| Sep 7, 2026 | Wapnick Pamela M.Chief Financial Officer | Sale at price 1.16 per share. | 1.9K | $2.21K |
| Sep 7, 2026 | Wein MatthewGeneral Counsel | Sale at price 1.16 per share. | 358 | $415 |
| Sep 7, 2026 | Irish JianChief Executive Officer | Sale at price 1.16 per share. | 2.1K | $2.48K |
| Jun 4, 2026 | Wapnick Pamela M.Chief Financial Officer | Sale at price 1.30 per share. | 2.9K | $3.75K |
| Jun 4, 2026 | Wein MatthewGeneral Counsel | Sale at price 1.30 per share. | 558 | $725 |
| Jun 4, 2026 | Irish JianChief Executive Officer | Sale at price 1.30 per share. | 3.7K | $4.85K |
| Mar 31, 2026 | Wapnick Pamela M.Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 24K | — |
| Mar 31, 2026 | Wein MatthewGeneral Counsel | Stock Award(Grant) at price 0.00 per share. | 11K | — |
| Mar 31, 2026 | Irish JianChief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 46K | — |
| Mar 4, 2026 | Wapnick Pamela M.Chief Financial Officer | Sale at price 1.60 per share. | 1.6K | $2.53K |
| Mar 4, 2026 | Wein MatthewGeneral Counsel | Sale at price 1.60 per share. | 482 | $771 |
| Mar 4, 2026 | Irish JianChief Executive Officer | Sale at price 1.60 per share. | 1.6K | $2.57K |
| Dec 4, 2025 | Wapnick Pamela M.Chief Financial Officer | Sale at price 1.77 per share. | 1.6K | $2.79K |
| Dec 4, 2025 | Thomas Brian CDirector | Sale at price 1.77 per share. | 3.8K | $6.79K |
| Dec 4, 2025 | Wein MatthewGeneral Counsel | Sale at price 1.77 per share. | 199 | $353 |
| Dec 4, 2025 | Irish JianChief Executive Officer | Sale at price 1.77 per share. | 1.6K | $2.84K |
| Dec 4, 2025 | Irish JianChief Executive Officer | Stock Gift at price 0.00 per share. | 228.5K | — |
| Nov 30, 2025 | Wapnick Pamela M.Chief Financial Officer | Stock Award(Grant) at price 1.60 per share. | 120K | $192.00K |
| Nov 30, 2025 | Wein MatthewGeneral Counsel | Stock Award(Grant) at price 1.60 per share. | 96K | $153.60K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -4.9 | -1.3 | -11.8 | 3.0 | -1.4 | -12.5 | 0.0 | -0.8 | -10.2 | -18.8 | −46.8% | ||
| 2025 | -25.5 | -23.8 | -33.7 | 27.2 | -1.7 | -12.9 | 55.4 | -24.3 | 36.2 | 7.2 | -31.1 | -7.4 | −55.1% |
| 2024 | -11.0 | -33.5 | -9.1 | -36.1 | -4.9 | -23.5 | -26.9 | -9.2 | 5.1 | 74.4 | −69.6% |
Metagenomi Therapeutics, Inc. an in vivo genome editing company, develops curative genetic medicines in the United States. The company's lead development program, MGX-001, is designed to provide curative, life-long protection from bleeding events and joint damage in adults and children with hemophilia. It has a collaboration agreement with Ionis Pharmaceuticals, Inc. for apolipoprotein C-III for the treatment of hyper triglyceridemia, transthyretin (TTR) for transthyretin amyloidosis, angiotensinogen (AGT) for refractory hypertension, and other programs. The company was formerly known as Metagenomi, Inc. and changed its name to Metagenomi Therapeutics, Inc. in January 2026. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.
Buy / hold / sell counts